BMXMF
BIOMERIEUX 69 MARCY NEW by Biomerieux 69 Marcy L'Etoile (BMXMF)
$
75About BIOMERIEUX 69 MARCY NEW by Biomerieux 69 Marcy L'Etoile (BMXMF)
bioMérieux SA engages in the provision of in vitro diagnostic solutions, which determine the source of disease and contamination. It develops testing, detection, and other laboratory system for the analysis of cancer, diseases, and infections caused by bacteria, virus, and fungi. The company was founded Alain Mérieux in 1963 and is headquartered in Marcy l'Etoile, France.
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$131.75
52 Week Low
$93.50
Market cap
15.4B
Dividend yield
0.70%
Volume
--
Avg. volume
8
P/E ratio
32.98
BIOMERIEUX 69 MARCY NEW by Biomerieux 69 Marcy L'Etoile News
Details
Daily high
--
Daily low
--
Price at open
--
52 Week High
$131.75
52 Week Low
$93.50
Market cap
15.4B
Dividend yield
0.70%
Volume
--
Avg. volume
8
P/E ratio
32.98